We are live on ! Find out more
KLRS

Kalaris Therapeutics

Name Holding Trade Value Shares
Change
Change in
Stake
SB
1
Samsara BioCapital
California
$74.7M
RI
2
RTW Investments
New York
$7.5M
PBA
3
Paradigm Biocapital Advisors
New York
$4.04M
Alyeska Investment Group
4
Alyeska Investment Group
Illinois
$3.27M +$1.5M +169,136 +42%
SL
5
Siren LLC
Connecticut
$2.51M
IC
6
Ikarian Capital
Texas
$2.08M
PBM
7
Propel Bio Management
California
$1.72M +$2.25M +253,718 +603%
Vanguard Capital Management
8
Vanguard Capital Management
Pennsylvania
$1.47M +$2.27M +255,348 New
KCM
9
Kalehua Capital Management
Texas
$782K -$38.3K -4,316 -3%
Raymond James Financial
10
Raymond James Financial
Florida
$686K +$270K +30,451 +34%
Goldman Sachs
11
Goldman Sachs
New York
$638K +$676K +76,200 +222%
ACM
12
ADAR1 Capital Management
Texas
$577K
WP
13
Woodline Partners
California
$577K
WT
14
WHI Trust
Illinois
$563K
BFM
15
Boothbay Fund Management
New York
$532K
Geode Capital Management
16
Geode Capital Management
Massachusetts
$505K +$43.5K +4,898 +6%
SAM
17
Simplify Asset Management
Nevada
$504K +$598K +67,352 +336%
Marshall Wace
18
Marshall Wace
United Kingdom
$392K -$44.3K -4,997 -7%
Renaissance Technologies
19
Renaissance Technologies
New York
$382K -$192K -21,600 -25%
Millennium Management
20
Millennium Management
New York
$344K +$528K +59,534 New
Susquehanna International Group
21
Susquehanna International Group
Pennsylvania
$304K +$353K +39,828 +310%
6CM
22
683 Capital Management
New York
$260K -$316K -35,590 -44%
BAM
23
Belpointe Asset Management
Nevada
$231K
FCA
24
Fortis Capital Advisors
Kansas
$231K
Squarepoint
25
Squarepoint
New York
$229K +$128K +14,406 +57%